| human | Q5 |
| P269 | IdRef ID | 160251222 |
| P2798 | Loop ID | 436480 |
| P496 | ORCID iD | 0000-0001-9521-0067 |
| P1053 | ResearcherID | H-8138-2019 |
| P1153 | Scopus author ID | 7103128229 |
| P214 | VIAF ID | 291983120 |
| P108 | employer | Centre de recherche de Jouy-en-Josas | Q30281526 |
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q58802438 | Addition of dairy lipids and probiotic Lactobacillus fermentum in infant formula programs gut microbiota and entero-insular axis in adult minipigs |
| Q43783927 | Both pH and carbon flux influence the level of rubredoxin in Clostridium butyricum. |
| Q62027647 | Characterization of Cecal Microbiota and Response to an Orally Administered Lactobacillus Probiotic Strain in the Broiler Chicken |
| Q47958928 | Distribution of the rubredoxin gene among the Clostridium butyricum species. |
| Q74673376 | Effect of glucose on glycerol metabolism by Clostridium butyricum DSM 5431 |
| Q57153334 | Effect of prebiotic carbohydrates on growth, bile survival and cholesterol uptake abilities of dairy-related bacteria |
| Q44487883 | Expression and purification of FtsW and RodA from Streptococcus pneumoniae, two membrane proteins involved in cell division and cell growth, respectively. |
| Q91797942 | Fecal microbiome as determinant of the effect of diet on colorectal cancer risk: comparison of meat-based versus pesco-vegetarian diets (the MeaTIc study) |
| Q42931889 | Germ-free C57BL/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism. |
| Q48261800 | Gut Microbiome and Obesity. How to Prove Causality? |
| Q53489619 | Gut microbiota and obesity. |
| Q34714843 | Harnessing the beneficial properties of adipogenic microbes for improving human health. |
| Q34678541 | High fat diet drives obesity regardless the composition of gut microbiota in mice |
| Q74667211 | Human haptocorrin in hepatocellular carcinoma |
| Q35862699 | Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease. |
| Q34496310 | Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice. |
| Q35147785 | Metabolic interplay between gut bacteria and their host |
| Q34533691 | Metabolism of cholesterol and bile acids by the gut microbiota. |
| Q93379690 | Microbial impact on cholesterol and bile acid metabolism: current status and future prospects |
| Q38608578 | Microbiota, Liver Diseases, and Alcohol. |
| Q92882653 | Murine Genetic Background Overcomes Gut Microbiota Changes to Explain Metabolic Response to High-Fat Diet |
| Q46462463 | Rapid analysis of bile acids in different biological matrices using LC-ESI-MS/MS for the investigation of bile acid transformation by mammalian gut bacteria |
| Q38671448 | Recent Patents on Hypocholesterolemic Therapeutic Strategies: An Update. |
| Q46311718 | Reduced obesity, diabetes and steatosis upon cinnamon and grape pomace are associated with changes in gut microbiota and markers of gut barrier. |
| Q34948505 | Short-chain fructo-oligosaccharides modulate intestinal microbiota and metabolic parameters of humanized gnotobiotic diet induced obesity mice |
| Q91402978 | Steatosis and gut microbiota dysbiosis induced by high-fat diet are reversed by 1-week chow diet administration |
| Q41109274 | The Effects of Weaning Methods on Gut Microbiota Composition and Horse Physiology. |
| Q57112600 | The gut microbiota drives the impact of bile acids and fat source in diet on mouse metabolism |
| Q91494290 | The intestinal microbiota regulates host cholesterol homeostasis |
| Q91229683 | The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD) |
| Q92036399 | The role of microbiota in tissue repair and regeneration |
Search more.